Fake news? Narcan maker forced to refute licensing deal after wire service apparently duped by false announcement

While most everyone was in a TGIF mood and getting ready for the weekend, Opiant Pharmaceuticals spent last Friday afternoon fending off a fake press release. The Santa Monica, CA-based biotech’s stock shot up early Friday on reports that it had agreed to a licensing deal with Hikma Pharmaceuticals on…

...

Click to view original post